Provided by Tiger Trade Technology Pte. Ltd.

TELA Bio, Inc.

0.8141
+0.00330.41%
Post-market: 0.8003-0.0138-1.70%19:05 EST
Volume:127.30K
Turnover:102.34K
Market Cap:36.25M
PE:-0.92
High:0.8700
Open:0.8200
Low:0.7817
Close:0.8108
52wk High:2.96
52wk Low:0.6759
Shares:44.53M
Float Shares:21.67M
Volume Ratio:0.11
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8852
EPS(LYR):-1.3265
ROE:-676.41%
ROA:-38.68%
PB:23.28
PE(LYR):-0.61

Loading ...

TELA Bio Grants Restricted Stock Units to New Employees

Reuters
·
Jan 26

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jan 24

Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly

Reuters
·
Dec 23, 2025

TELA Bio Grants Restricted Stock Units to New Employees

Reuters
·
Dec 13, 2025

TELA Bio Inc - Registers 2,000,000 Shares for Resale - SEC Filing

THOMSON REUTERS
·
Dec 12, 2025

TELA Bio Is Maintained at Buy by Lake Street

Dow Jones
·
Dec 02, 2025

Tela Bio Appoints William Plovanic To Board Of Directors

Reuters
·
Nov 20, 2025

TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire
·
Nov 19, 2025

TELA Bio Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Nov 18, 2025

Strategic Initiatives and Financial Adjustments Underpin Buy Rating for TELA Bio Despite Short-term Challenges

TIPRANKS
·
Nov 18, 2025

Tela Bio price target lowered to $4 from $7 at Canaccord

TIPRANKS
·
Nov 18, 2025

EW Healthcare Partners Fund 2 Acquires Common Shares of TELA Bio Inc

Reuters
·
Nov 18, 2025

TELA Bio Grants Stock Options and Restricted Units to New Employees

Reuters
·
Nov 18, 2025

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Nov 18, 2025

TELA Bio Secures $70 Million Term Loan Facility from Perceptive Credit Holdings

Reuters
·
Nov 15, 2025

TELA Bio Is Maintained at Market Outperform by Citizens

Dow Jones
·
Nov 14, 2025

Tela Bio price target lowered to $1.25 from $2 at Piper Sandler

TIPRANKS
·
Nov 14, 2025

Positive Sentiment Still Eludes TELA Bio, Inc. (NASDAQ:TELA) Following 26% Share Price Slump

Simply Wall St.
·
Nov 14, 2025

TELA Bio Reports Q3 Revenue Growth and New Credit Facility

TIPRANKS
·
Nov 14, 2025

Press Release: TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants

Dow Jones
·
Nov 14, 2025